|
|
|
±Ù½Ã ÁøÇà ¾ïÁ¦ ¾È°æ·»Áî ¡®¿¡½Ç·Î ½ºÅÚ¸®½ºÆ®¡¯ À̺¥Æ® |
±Û·Î¹ú ¾È°æ·»Áî Àü¹® ±â¾÷ ¿¡½Ç·ÎÄÚ¸®¾Æ |
|
|
±Û·Î¹ú ¾È°æ·»Áî Àü¹® ±â¾÷ ¿¡½Ç·ÎÄÚ¸®¾Æ°¡ ¾î¸°À̳¯À» ¸Â¾Æ 5¿ù ÇÑ ´Þ°£ ¾î¸°ÀÌ ±Ù½Ã ÁøÇà ¾ïÁ¦ ¾È°æ·»Áî ‘¿¡½Ç·Î ½ºÅÚ¸®½ºÆ®’ ±¸¸Å ½Ã µ¶¼´ë¸¦ ÁõÁ¤ÇÏ´Â À̺¥Æ®¸¦ ÁøÇàÇÑ´Ù.
À̹ø À̺¥Æ®´Â ¿¡½Ç·ÎÄÚ¸®¾Æ°¡ ±Ù½Ã ±³Á¤°ú ±Ù½Ã ¾ïÁ¦¸¦ ÇÑ ¹ø¿¡ ÇÒ ¼ö ÀÖ´Â ‘¿¡½Ç·Î ½ºÅÚ¸®½ºÆ®’¸¦ º¸´Ù ¸¹Àº ¼ÒºñÀÚ¿¡°Ô ¼Ò°³Çϰí, ¾î¸°À̵éÀÇ °Ç°ÇÑ ½Ã·Â°ú ¿Ã¹Ù¸¥ µ¶¼ ½À°ü Çü¼ºÀ» ÀÀ¿øÇϱâ À§ÇØ ¸¶·ÃÇß´Ù.
Çà»ç ±â°£ Áß ¾È°æ¿ø¿¡¼ ‘¿¡½Ç·Î ½ºÅÚ¸®½ºÆ®’¸¦ ÁÖ¹®ÇÑ °í°´¿¡°Ô´Â ¹Ù¸¥ ÀÚ¼¼¸¦ À¯µµÇÏ´Â 360µµ ȸÀüÇü ÇÁ¸®¹Ì¾ö µ¶¼´ë°¡ Á¦°øµÈ´Ù. »çÀºÇ°Àº ¾È°æ·»Á ¼ö·ÉÇÒ ¶§ ÇÔ²² ¹ÞÀ» ¼ö ÀÖÀ¸¸ç, ¼ö·® ÇÑÁ¤À¸·Î Á¶±â ¼ÒÁøµÉ ¼ö ÀÖ´Ù.
¾È°æ·»Áî ‘¿¡½Ç·Î ½ºÅÚ¸®½ºÆ®’´Â ·»Áî Ç¥¸éÀÇ 40%¿¡ 1021°³ÀÇ ¸¶ÀÌÅ©·Î·»Á 11°³ÀÇ ¸µ ÇüÅ·Π¹èÄ¡ÇÑ °íµµÈµÈ ºñ±¸¸é ¸¶ÀÌÅ©·Î·»Áî ±â¼úÀ» Àû¿ëÇØ ¸ÅÀÏ 12½Ã°£ Âø¿ë ½Ã ±Ù½Ã ÁøÇàÀ» 67% ¾ïÁ¦ÇÑ´Ù[1]. ÀÏ¹Ý ´ÜÃÊÁ¡ ¾È°æ·»Áî¿Í °°Àº ¼±¸íÇÑ ½Ã¾ß¸¦ Á¦°øÇØ[2] ÀÏ»ó»ýȰÀÇ ºÒÆíÇÔ ¾øÀÌ ±Ù½Ã¸¦ °ü¸®ÇÒ ¼ö ÀÖ´Ù.
¶ÇÇÑ, ÀÓ»ó¿¡¼ ‘¿¡½Ç·Î ½ºÅÚ¸®½ºÆ®’ ¾È°æ·»Á Âø¿ëÇÑ ¾î¸°ÀÌÀÇ 90%°¡ 3ÀÏ À̳»¿¡ ÀûÀÀÇßÀ¸¸ç, ÀÏÁÖÀÏ À̳»·Î ¸ðµç ¾î¸°À̰¡ ÀûÀÀÇÑ °ÍÀ¸·Î ³ªÅ¸³µ´Ù[3]. ´Ü, °³Àο¡ µû¶ó Â÷À̰¡ ÀÖÀ» ¼ö ÀÖ¾î 2ÁÖ Á¤µµÀÇ ÀûÀÀ ±â°£À» ±ÇÀåÇÑ´Ù.
¿¡½Ç·ÎÄÚ¸®¾Æ ¼ÒÈ¿¼ø ´ëÇ¥´Â “°¡Á¤ÀÇ ´ÞÀ» ¸Â¾Æ, ½Ã·Â °ü¸®°¡ Áß¿äÇÑ ¼ºÀå±â ¾î¸°À̵鿡°Ô ¾î¶² µµ¿òÀ» ÁÙ ¼ö ÀÖÀ»Áö ºÎ¸ðÀÇ ¸¶À½À¸·Î °í¹ÎÇß´Ù”¸ç “À̹ø ‘¿¡½Ç·Î ½ºÅÚ¸®½ºÆ®’ À̺¥Æ®°¡ ÀÚ³àÀÇ ´« °Ç°Àº ¹°·Ð ÀÏ»ó»ýȰ ¼Ó ¿Ã¹Ù¸¥ µ¶¼ ½À°ü±îÁö ÇÔ²² ì±æ ¼ö ÀÖ´Â ±âȸ°¡ µÇ±â¸¦ ¹Ù¶õ´Ù”°í ¸»Çß´Ù.
ÇÑÆí, ‘¿¡½Ç·Î ½ºÅÚ¸®½ºÆ® ¾È°æ¿ø °Ë»ö À¥ ÆäÀÌÁö( https://www.stellest.co.kr)’¸¦ ÅëÇØ °¡±î¿î Ãë±Þ ¾È°æ¿øÀ» ½±°Ô ãÀ» ¼ö ÀÖ´Ù. ‘¿¡½Ç·Î ½ºÅÚ¸®½ºÆ®’¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ Á¤º¸´Â ¿¡½Ç·ÎÄÚ¸®¾Æ °ø½Ä ȨÆäÀÌÁö( https://www.essilor.com/kr-ko) ¶Ç´Â ¿¡½Ç·Î ½ºÅÚ¸®½ºÆ® °ø½Ä ºí·Î±×( https://blog.naver.com/essilor_stellest)¸¦ ÅëÇØ È®ÀÎ °¡´ÉÇÏ´Ù.
[1] Áß±¹ ¿øÀú¿ì¿¡¼ ¿¡½Ç·Î ½ºÅÚ¸®½ºÆ®¸¦ Âø¿ëÇÑ ±Ù½Ã ¾î¸°ÀÌ 54¸í°ú ¿¡½Ç·Î ·è¼ÒƼī ÀÚ»çÀÇ ´ÜÃÊÁ¡ ·»Á Âø¿ëÇÑ ±Ù½Ã ¾î¸°ÀÌ 50¸íÀ» ´ë»óÀ¸·Î ÇÑ 2³â°£ÀÇ ÀüÇâÀû, ´ëÁ¶±ºÀÌ ÀÖ´Â, ¹«ÀÛÀ§¹èÁ¤, ÀÌÁß¸Í°Ë ÀÓ»ó½ÃÇè °á°ú. 32¸íÀÇ ¾î¸°À̵éÀÌ ¿¬¼Ó 2³â µ¿¾È ¸ÅÀÏ ÃÖ¼Ò 12½Ã°£ ¿¡½Ç·Î ½ºÅÚ¸®½ºÆ®¸¦ Âø¿ë½Ã. Bao J, Huang Y, Li X, Yang A, Zhou F, Wu J, Wang C, Li Y, Lim EW, Spiegel DP, Drobe B, Chen, H. Spectacle lenses with aspherical lenslets for myopia control vs single-vision spectacle lenses: a randomized clinical trial. JAMA ophthalmology. 2022;140(5):472-8. doi:10.1001/jamaophthalmol.2022.0401
[2] Two-year prospective, controlled, randomized, double-masked clinical trial results on 54 myopic children wearing Stellest® lenses compared to 50 myopic children wearing single vision lenses. Results based on 32 children who declared wearing Stellest® lenses at least 12 hours per day every day. Bao, J. et al. (2021). One-year myopia control efficacy of spectacle lenses with aspherical lenslets. Br. J. Ophthalmol. doi:10.1136/bjophthalmol-2020-318367.
[3] ¿¡½Ç·Î ½ºÅÚ¸®½ºÆ® ¾È°æ·»Á Âø¿ëÇÑ 54¸íÀÇ ±Ù½Ã ¾Æµ¿°ú ¿¡½Ç·Î ·è¼ÒƼī ±×·ìÀÇ ´ÜÃÊÁ¡ ·»Á Âø¿ëÇÑ 50¸íÀÇ ±Ù½Ã ¾Æµ¿À» ´ë»óÀ¸·Î ÇÑ 2³â°£ÀÇ ÀüÇâÀû, ´ëÁ¶Àû, ¹«ÀÛÀ§¹èÁ¤, ÀÌÁß¸Í°Ë ÀÓ»ó½ÃÇèÀÇ 1³â °á°ú. Bao J,Yang A, Huang Y, Li X, Pan Y, Ding C, Lim EW, Zheng J, Spiegel DP, Drobe B, Lu F. One-year myopia control efficacy of spectacle lenses withaspherical lenslets. British Journal of Ophthalmology. 2022;106(8):1171-6.
Ãâó : ¿¡½Ç·ÎÄÚ¸®¾Æ
|
|
Àüü´º½º¸ñ·ÏÀ¸·Î |
|
|
|
|
|